Ascus Biosciences is a biotechnology and life sciences startup based in San Diego, California. Since its founding in 2015, the company has been dedicated to developing computational and genomics-based technology to create next-generation microbial products. This approach sets Ascus Biosciences apart in the biotech industry, positioning it as an innovative player in the field.
The most recent milestone for Ascus Biosciences was its $46.00M Series B investment, which took place on 27 May 2020. The investors in this round included prominent names such as Formation 8, Anterra Capital, Temasek Holdings, and Cavallo Ventures. This significant investment reflects the market's confidence in the company's vision and technology.
As Ascus Biosciences continues to advance its unique technology platform, it is poised to make a substantial impact within the biotech and life sciences industries. With its solid base in San Diego, a renowned hub for biotech innovation, the company is well positioned to drive meaningful change and breakthroughs in microbial product development.
